… Patients with iron deficiency anaemia (IDA) in the setting of non-dialysis-… from treatment
with intravenous (IV) iron. Ferric carboxymaltose (FCM) is a novel IV iron formulation designed to …

… denominated as anemia of chronic disease (ACD), but the association with true ferropenic
anemia is common. Many studies have investigated the effects of treating anemia in HF …

… Intravenous (IV) iron is often used to treat iron deficiency anemia in patients who are unable
to tolerate or are inadequately managed with oral iron. However, IV iron treatment has been …

… Anemia develops early in the course of … design, potential for co-intervention and observer
biases, high drop-out rate (25% over 6 months) and failure to analyse on an intention to treat …

… and preoperative intravenous (IV) iron therapy thus may improve anemia and … treatment of
anemia before cardiac surgery (ITACS) Trial to test the hypothesis that in patients with anemia …

… Using darbepoetin alfa, an ESA commonly used to treat anemia in CKD patients, we aim to
gather a wide range of clinical information of ESA therapy to investigate the status of patients …

… 24 months prior to start of treatment Anaemia due to reasons other than iron deficiency (eg
haemoglobinopathy) On optimal pharmacological treatment which includes a diuretic, a beta-…

… The primary study endpoint will be severe hematological toxicities that occur during the
fixed-dose treatment phase. REACH has an adaptive statistical design that allows for careful …

… outcomes independent of baseline anemia. Several studies have shown … anemia. Similarly,
other international guidelines have recommended this treatment be considered for ID anemia…

… Ferric CarboxymaltOse evaluatioN on perFormance in patients with IRon deficiency in
coMbination with chronic Heart Failure (CONFIRM-HF) was designed to test a simplifieddosage …